Medispend expands Revenue Management leadership with addition of Chanan Greenberg. * 26 May 2026 Medispend is excited to welcome Chanan Greenberg as General Manager of Revenue Management Solutions, further strengthening the company's investment in helping life sciences organizations navigate the growing complexity of commercialization, pricing, and market access. As the life sciences industry continues to evolve, Revenue Management has become increasingly critical to operational success. Organizations are facing mounting pressure to manage pricing strategies, contracting, rebates, government programs, and compliance requirements with greater accuracy, visibility, and efficiency. Medispend's continued growth in this area reflects both the needs of the market and the company's long-term commitment to delivering innovative, connected solutions that support customers across the commercialization lifecycle. Chanan joins Medispend with extensive industry experience and a strong track record of leadership, strategic growth, and operational execution. In his role, he will lead the continued expansion and advancement of Medispend's Revenue Management Solutions business, working closely with customers and teams across the organization to drive innovation and deliver meaningful value to the market. "Revenue Management is a strategic growth area for Medispend, and we're thrilled to welcome Chanan to the team," said Chris Gingras, President. "His leadership experience, industry knowledge, and customer-first mindset make him an excellent fit as we continue expanding our capabilities and supporting the evolving needs of life sciences organizations." Chanan's addition comes at an important time as Medispend continues investing in technology and expertise that help customers simplify complexity, improve operational performance, and adapt to an increasingly dynamic healthcare landscape. "I'm excited to join Medispend and be part of a company that is deeply focused on innovation and customer success," said Greenberg. "There is tremendous opportunity ahead in Revenue Management, and I look forward to working with the team to help organizations navigate challenges, drive efficiency, and support better business outcomes." The addition of Chanan reflects Medispend's broader commitment to building industry-leading solutions and leadership teams that empower life sciences organizations to operate more strategically, compliantly, and effectively. Life sciences companies don't struggle with strategy, they struggle with executing that strategy at scale. Across Compliance, Medical Affairs, Commercial, Finance, and IT, a consistent Federal contracting expectations are changing, again. And this time, the implications for pharmaceutical manufacturers participating in VA and Federal Supply Schedule (FSS) contracting are significant. Coaching has long been a cornerstone of leadership in life sciences organizations, especially across sales teams. But as roles grow more complex, expectations increase, and Contact MediSpend Ready to grow your business compliantly? MediSpend is happy to answer any questions you may have and help you determine which of its solutions and services best fit your needs. Why Medispend: * Life Sciences Focused * End-to-End Solutions * Regulatory Expertise * Enterprise Scalability * Advanced Analytics * Trusted Partnership What happens next? Contact MediSpend. Medispend uses the contact information you provide to MediSpend to contact you about its products and services. You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as its privacy practices and commitment to protecting your privacy, check out its Privacy Policy.

MediSpend and RLDatix Life Sciences have merged to form a leading global provider of regulatory and compliance SaaS solutions for the life sciences industry. The new company offers comprehensive software, data, and workflow tools for pharmaceutical, biotech, and medical device companies, serving over 300 clients worldwide. Supported by Five Arrows, Susquehanna Growth Equity, TA Associates, and Nordic Capital, the merger combines expertise in compliance, transparency, and sales enablement.